Literature DB >> 10464873

A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A.

M Luisetti1, G Massi, M Massobrio, P Guarraci, F M Menchicchi, M Beccaria, B Balbi.   

Abstract

alpha 1-antitrypsin (AAT) deficiency is an inherited condition characterized by low serum levels of AAT and an increased risk of developing pulmonary emphysema. The disease occurs mainly in Caucasians, but Southern Europe, including Italy, is considered a low prevalence area. We developed a national program in Italy in order to improve our knowledge of the epidemiology of AAT deficiency and to establish a registry of the AAT-deficient individuals. The program had two phases: the first lasted 36 months, during which blood from coupons mailed by respiratory physicians from throughout the country, was isoelectrofocused by the Central Laboratory in Rome. The second phase started in February 1996, and the Registry was established. Up to August 1998, 151 subjects with AAT deficiency have been identified and 64 have been enrolled in the Registry. We believe that such a program plays a crucial role in identifying AAT deficiency in a country such as Italy, with low prevalence and low awareness of this rare condition.

Entities:  

Mesh:

Year:  1999        PMID: 10464873     DOI: 10.1016/s0954-6111(99)90003-3

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects.

Authors:  M Malerba; F Ricciardolo; A Radaeli; C Torregiani; L Ceriani; E Mori; M Bontempelli; C Tantucci; V Grassi
Journal:  Thorax       Date:  2005-11-11       Impact factor: 9.139

Review 2.  Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.

Authors:  Timm Greulich; Claus F Vogelmeier
Journal:  Ther Adv Respir Dis       Date:  2015-09-04       Impact factor: 4.031

3.  Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.

Authors:  Myriam Calle Rubio; Joan B Soriano; José Luis López-Campos; Juan J Soler-Cataluña; Bernardino Alcázar Navarrete; José Miguel Rodríguez González-Moro; Marc Miravitlles; Miriam Barrecheguren; Manuel E Fuentes Ferrer; Juan Luis Rodriguez Hermosa
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

4.  Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.

Authors:  Timm Greulich; Christoph Nell; Christian Herr; Claus Vogelmeier; Viktor Kotke; Stefan Wiedmann; Marion Wencker; Robert Bals; Andreas Rembert Koczulla
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.